AAAAAA

   
Results: 1-20 |
Results: 20
PROPHYLACTIC THYROIDECTOMY IN MEN IIA - DOES THE CALCITONIN LEVEL CORRELATE WITH TUMOR SPREAD
Authors: HOTZ HG RUNKEL NSF FRANKRAUE K RAUE F BUHR HJ
Citation: Hg. Hotz et al., PROPHYLACTIC THYROIDECTOMY IN MEN IIA - DOES THE CALCITONIN LEVEL CORRELATE WITH TUMOR SPREAD, LANGENBECKS ARCHIVES OF SURGERY, 383(2), 1998, pp. 170-173
PROPHYLACTIC THYROIDECTOMY IN 75 CHILDREN AND ADOLESCENTS WITH HEREDITARY MEDULLARY-THYROID CARCINOMA - GERMAN AND AUSTRIAN EXPERIENCE
Authors: DRALLE H GIMM O SIMON D FRANKRAUE K GORTZ G NIEDERLE B WAHL RA KOCH B WALGENBACH S HAMPEL R RITTER MM SPELSBERG F HEISS A HINZE R HOPPNER W
Citation: H. Dralle et al., PROPHYLACTIC THYROIDECTOMY IN 75 CHILDREN AND ADOLESCENTS WITH HEREDITARY MEDULLARY-THYROID CARCINOMA - GERMAN AND AUSTRIAN EXPERIENCE, World journal of surgery, 22(7), 1998, pp. 744-751
A NEW HOT-SPOT FOR MUTATIONS IN THE RET PROTOONCOGENE CAUSING FAMILIAL MEDULLARY-THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A
Authors: BERNDT I REUTER M SALLER B FRANKRAUE K GROTH P GRUSSENDORF M RAUE F RITTER MM HOPPNER W
Citation: I. Berndt et al., A NEW HOT-SPOT FOR MUTATIONS IN THE RET PROTOONCOGENE CAUSING FAMILIAL MEDULLARY-THYROID CARCINOMA AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 770-774
MUTATION OF REF-PROTO-ONCOGENE IN MEDULLA RY-THYROID CARCINOMA
Authors: FRANKRAUE K HOPPNER W BUHR H HERFARTH C ZIEGLER R RAUE F
Citation: K. Frankraue et al., MUTATION OF REF-PROTO-ONCOGENE IN MEDULLA RY-THYROID CARCINOMA, Deutsche Medizinische Wochenschrift, 122(6), 1997, pp. 143-149
PROPHYLACTIC THYROIDECTOMY IN MEN IIA GENE CARRIERS - AN INTERVENTIONWITH A JUSTIFIABLE MORBIDITY
Authors: HOTZ HG RUNKEL N FRANKRAUE K RAUE F BUHR HJ
Citation: Hg. Hotz et al., PROPHYLACTIC THYROIDECTOMY IN MEN IIA GENE CARRIERS - AN INTERVENTIONWITH A JUSTIFIABLE MORBIDITY, European journal of cancer, 33, 1997, pp. 1234-1234
RESULTS AND FOLLOW-UP IN 11 MEN 2A GENE CARRIERS AFTER PROPHYLACTIC THYROIDECTOMY
Authors: FRANKRAUE K HOPPNER W BUHR H HERFARTH C RAUE F
Citation: K. Frankraue et al., RESULTS AND FOLLOW-UP IN 11 MEN 2A GENE CARRIERS AFTER PROPHYLACTIC THYROIDECTOMY, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105, 1997, pp. 76-78
APPLICATION OF GENETIC SCREENING IN FAMILIES WITH HEREDITARY MEDULLARY-THYROID CARCINOMA
Authors: FRANKRAUE K HOPPNER W BUHR H HERFARTH C ZIEGLER R RAUE F
Citation: K. Frankraue et al., APPLICATION OF GENETIC SCREENING IN FAMILIES WITH HEREDITARY MEDULLARY-THYROID CARCINOMA, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 104, 1996, pp. 108-110
DIAGNOSIS AND MANAGEMENT OF PHEOCHROMOCYTOMAS IN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2-RELEVANCE OF SPECIFIC MUTATIONS IN THE RET PROTOONCOGENE
Authors: FRANKRAUE K KRATT T HOPPNER W BUHR H ZIEGLER R RAUE F
Citation: K. Frankraue et al., DIAGNOSIS AND MANAGEMENT OF PHEOCHROMOCYTOMAS IN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2-RELEVANCE OF SPECIFIC MUTATIONS IN THE RET PROTOONCOGENE, European journal of endocrinology, 135(2), 1996, pp. 222-225
THE RELATIONSHIP BETWEEN SPECIFIC RET PROTOONCOGENE MUTATIONS AND DISEASE PHENOTYPE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - INTERNATIONAL RET MUTATION CONSORTIUM ANALYSIS
Authors: ENG C CLAYTON D SCHUFFENECKER I LENOIR G COTE G GAGEL RF VANAMSTEL HKP LIPS CJM NISHISHO I TAKAI SI MARSH DJ ROBINSON BG FRANKRAUE K RAUE F XUE FY NOLL WW ROMEI C PACINI F FINK M NIEDERLE B ZEDENIUS J NORDENSKJOLD M KOMMINOTH P HENDY GN GHARIB H THIBODEAU SN LACROIX A FRILLING A PONDER BAJ MULLIGAN LM
Citation: C. Eng et al., THE RELATIONSHIP BETWEEN SPECIFIC RET PROTOONCOGENE MUTATIONS AND DISEASE PHENOTYPE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - INTERNATIONAL RET MUTATION CONSORTIUM ANALYSIS, JAMA, the journal of the American Medical Association, 276(19), 1996, pp. 1575-1579
MUTATIONS OF THE RET PROTOONCOGENE IN GERMAN MULTIPLE ENDOCRINE NEOPLASIA FAMILIES - RELATION BETWEEN GENOTYPE AND PHENOTYPE
Authors: FRANKRAUE K HOPPNER W FRILLING A KOTZERKE J DRALLE H HAASE R MANN K SEIF F KIRCHNER R RENDL J DECKART HF RITTER MM HAMPEL R KLEMPA J SCHOLZ GH RAUE F BOGNER U BRABANT G GRUSSENDORF M HARTENSTEIN CH HEIDEMANN P HENSEN J DORR AG HOHNE T HORNIGFRANZ I HUFNER M KRESS I LANGER HJ LOTTERMOSER K SCHWEIKERT HU KUSTERER K MENKEN U MERCIER J OELKERS W ZIEGLER R
Citation: K. Frankraue et al., MUTATIONS OF THE RET PROTOONCOGENE IN GERMAN MULTIPLE ENDOCRINE NEOPLASIA FAMILIES - RELATION BETWEEN GENOTYPE AND PHENOTYPE, The Journal of clinical endocrinology and metabolism, 81(5), 1996, pp. 1780-1783
THE HUMAN 3-BETA-HYDROXYSTEROID DEHYDROGENASE (3-BETA-HSD) GENE-CLUSTER ON CHROMOSOME 1P13 CONTAINS A PRESUMPTIVE PSEUDOGENE - 3-BETA-HSD AND CYP17 DO NOT SEGREGATE WITH DOMINANTLY INHERITED HIRSUTISM
Authors: MCBRIDE MW RUSSELL AJ VASS K FRANKRAUE K CRAIG NJ MORRISON N BOYD E SZPIRER C SUTCLIFFE RG
Citation: Mw. Mcbride et al., THE HUMAN 3-BETA-HYDROXYSTEROID DEHYDROGENASE (3-BETA-HSD) GENE-CLUSTER ON CHROMOSOME 1P13 CONTAINS A PRESUMPTIVE PSEUDOGENE - 3-BETA-HSD AND CYP17 DO NOT SEGREGATE WITH DOMINANTLY INHERITED HIRSUTISM, Journal of molecular endocrinology, 15(2), 1995, pp. 167-176
TREATMENT OF METASTASIZING MEDULLARY-THYR OID CARCINOMA WITH OCTREOTIDE
Authors: FRANKRAUE K RAUE F ZIEGLER R
Citation: K. Frankraue et al., TREATMENT OF METASTASIZING MEDULLARY-THYR OID CARCINOMA WITH OCTREOTIDE, Medizinische Klinik, 90(2), 1995, pp. 63-66
SOMATOSTATIN RECEPTOR IMAGING IN PERSISTENT MEDULLARY-THYROID CARCINOMA
Authors: FRANKRAUE K BIHL H DORR U BUHR H ZIEGLER R RAUE F
Citation: K. Frankraue et al., SOMATOSTATIN RECEPTOR IMAGING IN PERSISTENT MEDULLARY-THYROID CARCINOMA, Clinical endocrinology, 42(1), 1995, pp. 31-37
NEUTRALIZING ANTIBODIES AGAINST SALMON-CA LCITONIN - A CAUSE OF TREATMENT FAILURE IN PAGETS-DISEASE
Authors: GRAUER A FRANKRAUE K SCHROTH J RAUE F ZIEGLER R
Citation: A. Grauer et al., NEUTRALIZING ANTIBODIES AGAINST SALMON-CA LCITONIN - A CAUSE OF TREATMENT FAILURE IN PAGETS-DISEASE, Deutsche Medizinische Wochenschrift, 119(14), 1994, pp. 507-510
MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - CLINICAL-FEATURES AND SCREENING
Authors: RAUE F FRANKRAUE K GRAUER A
Citation: F. Raue et al., MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - CLINICAL-FEATURES AND SCREENING, Endocrinology and metabolism clinics of North America, 23(1), 1994, pp. 137-156
CHRONIC DIARRHEA AND CEA ELEVATION - A CO MBINATION SUSPICIOUS FOR MEDULLARY-THYROID CARCINOMA
Authors: FRANKRAUE K BUHR H RAUE F GRAUER A POUW F ZIEGLER R
Citation: K. Frankraue et al., CHRONIC DIARRHEA AND CEA ELEVATION - A CO MBINATION SUSPICIOUS FOR MEDULLARY-THYROID CARCINOMA, Tumordiagnostik & Therapie, 14(6), 1993, pp. 252-254
THE POTENTIAL VALUE OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN MEDULLARY-THYROID CARCINOMA
Authors: DORR U FRANKRAUE K RAUE F SAUTTERBIHL ML GUZMAN G BUHR HJ BIHL H
Citation: U. Dorr et al., THE POTENTIAL VALUE OF SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN MEDULLARY-THYROID CARCINOMA, Nuclear medicine communications, 14(6), 1993, pp. 439-445
THE USE OF OCTREOTIDE IN THE TREATMENT OF MEDULLARY-THYROID CARCINOMA
Authors: FRANKRAUE K ZIEGLER R RAUE F
Citation: K. Frankraue et al., THE USE OF OCTREOTIDE IN THE TREATMENT OF MEDULLARY-THYROID CARCINOMA, Hormone and Metabolic Research, 27, 1993, pp. 44-47
SOMATOSTATIN RECEPTOR SCINTIGRAPHY AND MAGNETIC-RESONANCE-IMAGING IN RECURRENT MEDULLARY-THYROID CARCINOMA - A COMPARATIVE-STUDY
Authors: DORR U WURSTLIN S FRANKRAUE K RAUE F HEHRMANN R ISER G SCHOLZ M GUHL L BUHR HJ BIHL H
Citation: U. Dorr et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY AND MAGNETIC-RESONANCE-IMAGING IN RECURRENT MEDULLARY-THYROID CARCINOMA - A COMPARATIVE-STUDY, Hormone and Metabolic Research, 27, 1993, pp. 48-55
MICROSURGICAL NECK DISSECTION FOR OCCULTLY METASTASIZING MEDULLARY-THYROID CARCINOMA - 3-YEAR RESULTS
Authors: BUHR HJ KALLINOWSKI F RAUE F FRANKRAUE K HERFARTH C
Citation: Hj. Buhr et al., MICROSURGICAL NECK DISSECTION FOR OCCULTLY METASTASIZING MEDULLARY-THYROID CARCINOMA - 3-YEAR RESULTS, Cancer, 72(12), 1993, pp. 3685-3693
Risultati: 1-20 |